Toe nail fungus New Patent Awarded For Vaccine Adjuvant Technology That Elicits Robust Immunity (Medical News Today)

A needle-free vaccine platform that elicits a robust immune response against a wide array of viruses and bacteria has been awarded a U.S. patent. The University of Michigan holds the patent and NanoBio Corporation, a spin-off from the university, licenses the patent and its associated technology.